nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS1—esophageal cancer	0.281	0.636	CbGaD
Ketoprofen—PTGS2—esophageal cancer	0.16	0.364	CbGaD
Ketoprofen—SLC22A11—Methotrexate—esophageal cancer	0.0557	0.152	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—esophageal cancer	0.053	0.145	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—esophageal cancer	0.0518	0.141	CbGbCtD
Ketoprofen—PTGS2—Cisplatin—esophageal cancer	0.0469	0.128	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—esophageal cancer	0.0372	0.101	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—esophageal cancer	0.0324	0.0884	CbGbCtD
Ketoprofen—CYP2C9—Capecitabine—esophageal cancer	0.0317	0.0864	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—esophageal cancer	0.0226	0.0616	CbGbCtD
Ketoprofen—ALB—Methotrexate—esophageal cancer	0.0192	0.0524	CbGbCtD
Ketoprofen—CYP2C9—Cisplatin—esophageal cancer	0.016	0.0435	CbGbCtD
Ketoprofen—Onycholysis—Capecitabine—esophageal cancer	0.00342	0.053	CcSEcCtD
Ketoprofen—CXCR1—lung—esophageal cancer	0.00235	0.133	CbGeAlD
Ketoprofen—Haemolysis—Cisplatin—esophageal cancer	0.00198	0.0306	CcSEcCtD
Ketoprofen—Gastrointestinal perforation—Capecitabine—esophageal cancer	0.00177	0.0275	CcSEcCtD
Ketoprofen—CXCR1—lymph node—esophageal cancer	0.00161	0.0913	CbGeAlD
Ketoprofen—Septicemia—Methotrexate—esophageal cancer	0.00152	0.0235	CcSEcCtD
Ketoprofen—Meningitis aseptic—Methotrexate—esophageal cancer	0.00146	0.0227	CcSEcCtD
Ketoprofen—CXCL8—bronchus—esophageal cancer	0.00129	0.0734	CbGeAlD
Ketoprofen—CXCL8—smooth muscle tissue—esophageal cancer	0.00126	0.0718	CbGeAlD
Ketoprofen—CXCL8—trachea—esophageal cancer	0.00116	0.0659	CbGeAlD
Ketoprofen—Hepatitis cholestatic—Capecitabine—esophageal cancer	0.00115	0.0178	CcSEcCtD
Ketoprofen—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.00103	0.016	CcSEcCtD
Ketoprofen—Proctalgia—Capecitabine—esophageal cancer	0.000987	0.0153	CcSEcCtD
Ketoprofen—CXCL8—lung—esophageal cancer	0.000833	0.0474	CbGeAlD
Ketoprofen—SLC22A11—digestive system—esophageal cancer	0.000826	0.047	CbGeAlD
Ketoprofen—SLC22A7—digestive system—esophageal cancer	0.000807	0.0459	CbGeAlD
Ketoprofen—Necrosis—Cisplatin—esophageal cancer	0.0008	0.0124	CcSEcCtD
Ketoprofen—Infection—Carboplatin—esophageal cancer	0.000759	0.0118	CcSEcCtD
Ketoprofen—Haematemesis—Capecitabine—esophageal cancer	0.000666	0.0103	CcSEcCtD
Ketoprofen—Hearing impaired—Cisplatin—esophageal cancer	0.00066	0.0102	CcSEcCtD
Ketoprofen—Haemoptysis—Capecitabine—esophageal cancer	0.000626	0.0097	CcSEcCtD
Ketoprofen—ABCC4—bronchus—esophageal cancer	0.000608	0.0346	CbGeAlD
Ketoprofen—CXCL8—lymph node—esophageal cancer	0.00057	0.0324	CbGeAlD
Ketoprofen—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000513	0.00795	CcSEcCtD
Ketoprofen—Skin discolouration—Capecitabine—esophageal cancer	0.000513	0.00795	CcSEcCtD
Ketoprofen—Deafness—Cisplatin—esophageal cancer	0.00051	0.0079	CcSEcCtD
Ketoprofen—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000503	0.00779	CcSEcCtD
Ketoprofen—Haematemesis—Methotrexate—esophageal cancer	0.000496	0.00769	CcSEcCtD
Ketoprofen—SLCO1A2—digestive system—esophageal cancer	0.000488	0.0278	CbGeAlD
Ketoprofen—Hearing impaired—Capecitabine—esophageal cancer	0.000486	0.00754	CcSEcCtD
Ketoprofen—Amnesia—Cisplatin—esophageal cancer	0.000485	0.00752	CcSEcCtD
Ketoprofen—ABCC4—digestive system—esophageal cancer	0.00047	0.0267	CbGeAlD
Ketoprofen—Hyponatraemia—Cisplatin—esophageal cancer	0.000458	0.0071	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000456	0.00707	CcSEcCtD
Ketoprofen—Melaena—Capecitabine—esophageal cancer	0.000452	0.00701	CcSEcCtD
Ketoprofen—Colitis—Capecitabine—esophageal cancer	0.000445	0.00689	CcSEcCtD
Ketoprofen—Face oedema—Cisplatin—esophageal cancer	0.00044	0.00682	CcSEcCtD
Ketoprofen—Necrosis—Methotrexate—esophageal cancer	0.000439	0.00681	CcSEcCtD
Ketoprofen—Mouth ulceration—Capecitabine—esophageal cancer	0.000419	0.00649	CcSEcCtD
Ketoprofen—SLCO1A2—lung—esophageal cancer	0.000408	0.0232	CbGeAlD
Ketoprofen—Sepsis—Capecitabine—esophageal cancer	0.000402	0.00623	CcSEcCtD
Ketoprofen—Carprofen—PTGS1—esophageal cancer	0.000399	0.0678	CrCbGaD
Ketoprofen—Ketorolac—PTGS1—esophageal cancer	0.000399	0.0678	CrCbGaD
Ketoprofen—ABCC4—lung—esophageal cancer	0.000392	0.0223	CbGeAlD
Ketoprofen—Diabetes mellitus—Capecitabine—esophageal cancer	0.000386	0.00599	CcSEcCtD
Ketoprofen—Pancreatitis—Cisplatin—esophageal cancer	0.000386	0.00599	CcSEcCtD
Ketoprofen—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000385	0.00596	CcSEcCtD
Ketoprofen—Photosensitivity—Capecitabine—esophageal cancer	0.000383	0.00593	CcSEcCtD
Ketoprofen—Bromfenac—PTGS1—esophageal cancer	0.000383	0.065	CrCbGaD
Ketoprofen—Skin discolouration—Methotrexate—esophageal cancer	0.000382	0.00592	CcSEcCtD
Ketoprofen—Deafness—Capecitabine—esophageal cancer	0.000376	0.00582	CcSEcCtD
Ketoprofen—Vascular purpura—Capecitabine—esophageal cancer	0.000376	0.00582	CcSEcCtD
Ketoprofen—Eye pain—Capecitabine—esophageal cancer	0.000372	0.00577	CcSEcCtD
Ketoprofen—PTGS1—epithelium—esophageal cancer	0.000364	0.0207	CbGeAlD
Ketoprofen—Increased appetite—Capecitabine—esophageal cancer	0.000358	0.00555	CcSEcCtD
Ketoprofen—Amnesia—Capecitabine—esophageal cancer	0.000358	0.00555	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000356	0.00552	CcSEcCtD
Ketoprofen—Thirst—Capecitabine—esophageal cancer	0.000353	0.00547	CcSEcCtD
Ketoprofen—Renal impairment—Capecitabine—esophageal cancer	0.000353	0.00547	CcSEcCtD
Ketoprofen—Dermatitis bullous—Capecitabine—esophageal cancer	0.000352	0.00545	CcSEcCtD
Ketoprofen—PTGS1—smooth muscle tissue—esophageal cancer	0.00035	0.0199	CbGeAlD
Ketoprofen—Purpura—Capecitabine—esophageal cancer	0.000349	0.00541	CcSEcCtD
Ketoprofen—PTGS2—epithelium—esophageal cancer	0.000348	0.0198	CbGeAlD
Ketoprofen—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000346	0.00537	CcSEcCtD
Ketoprofen—Renal failure—Cisplatin—esophageal cancer	0.000345	0.00535	CcSEcCtD
Ketoprofen—Myocardial infarction—Cisplatin—esophageal cancer	0.000344	0.00534	CcSEcCtD
Ketoprofen—Cardiac failure—Capecitabine—esophageal cancer	0.000344	0.00534	CcSEcCtD
Ketoprofen—Stomatitis—Cisplatin—esophageal cancer	0.000342	0.00531	CcSEcCtD
Ketoprofen—PTGS2—bronchus—esophageal cancer	0.000342	0.0195	CbGeAlD
Ketoprofen—Conjunctivitis—Cisplatin—esophageal cancer	0.000342	0.00529	CcSEcCtD
Ketoprofen—Hyponatraemia—Capecitabine—esophageal cancer	0.000337	0.00523	CcSEcCtD
Ketoprofen—Melaena—Methotrexate—esophageal cancer	0.000337	0.00522	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000336	0.00521	CcSEcCtD
Ketoprofen—PTGS2—smooth muscle tissue—esophageal cancer	0.000335	0.019	CbGeAlD
Ketoprofen—Migraine—Capecitabine—esophageal cancer	0.000331	0.00513	CcSEcCtD
Ketoprofen—Tiaprofenic acid—PTGS1—esophageal cancer	0.000325	0.0552	CrCbGaD
Ketoprofen—Face oedema—Capecitabine—esophageal cancer	0.000324	0.00503	CcSEcCtD
Ketoprofen—Aplastic anaemia—Methotrexate—esophageal cancer	0.000324	0.00502	CcSEcCtD
Ketoprofen—PTGS1—trachea—esophageal cancer	0.000322	0.0183	CbGeAlD
Ketoprofen—Mouth ulceration—Methotrexate—esophageal cancer	0.000312	0.00483	CcSEcCtD
Ketoprofen—Nepafenac—PTGS1—esophageal cancer	0.000309	0.0525	CrCbGaD
Ketoprofen—Gynaecomastia—Methotrexate—esophageal cancer	0.000308	0.00478	CcSEcCtD
Ketoprofen—PTGS2—trachea—esophageal cancer	0.000307	0.0175	CbGeAlD
Ketoprofen—Abdominal pain upper—Capecitabine—esophageal cancer	0.000307	0.00476	CcSEcCtD
Ketoprofen—Visual impairment—Cisplatin—esophageal cancer	0.000304	0.00471	CcSEcCtD
Ketoprofen—CYP2C9—digestive system—esophageal cancer	0.000303	0.0172	CbGeAlD
Ketoprofen—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000303	0.00469	CcSEcCtD
Ketoprofen—Magnesium salicylate—PTGS1—esophageal cancer	0.000302	0.0513	CrCbGaD
Ketoprofen—Sepsis—Methotrexate—esophageal cancer	0.000299	0.00464	CcSEcCtD
Ketoprofen—Gastritis—Capecitabine—esophageal cancer	0.000297	0.00461	CcSEcCtD
Ketoprofen—Fenbufen—PTGS1—esophageal cancer	0.000296	0.0502	CrCbGaD
Ketoprofen—Tinnitus—Cisplatin—esophageal cancer	0.000294	0.00456	CcSEcCtD
Ketoprofen—Flushing—Cisplatin—esophageal cancer	0.000293	0.00454	CcSEcCtD
Ketoprofen—Asthma—Capecitabine—esophageal cancer	0.00029	0.0045	CcSEcCtD
Ketoprofen—Diabetes mellitus—Methotrexate—esophageal cancer	0.000288	0.00446	CcSEcCtD
Ketoprofen—Bronchospasm—Capecitabine—esophageal cancer	0.000286	0.00443	CcSEcCtD
Ketoprofen—Photosensitivity—Methotrexate—esophageal cancer	0.000285	0.00442	CcSEcCtD
Ketoprofen—Arrhythmia—Cisplatin—esophageal cancer	0.000282	0.00437	CcSEcCtD
Ketoprofen—Alopecia—Cisplatin—esophageal cancer	0.000279	0.00432	CcSEcCtD
Ketoprofen—ALB—lymph node—esophageal cancer	0.000277	0.0158	CbGeAlD
Ketoprofen—PTGS1—digestive system—esophageal cancer	0.000277	0.0157	CbGeAlD
Ketoprofen—Erythema—Cisplatin—esophageal cancer	0.000275	0.00426	CcSEcCtD
Ketoprofen—Flatulence—Cisplatin—esophageal cancer	0.000271	0.00419	CcSEcCtD
Ketoprofen—ABCC4—lymph node—esophageal cancer	0.000268	0.0153	CbGeAlD
Ketoprofen—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000265	0.00411	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000265	0.00411	CcSEcCtD
Ketoprofen—PTGS2—digestive system—esophageal cancer	0.000264	0.015	CbGeAlD
Ketoprofen—Weight increased—Capecitabine—esophageal cancer	0.000264	0.0041	CcSEcCtD
Ketoprofen—Visual disturbance—Methotrexate—esophageal cancer	0.000264	0.00409	CcSEcCtD
Ketoprofen—Weight decreased—Capecitabine—esophageal cancer	0.000263	0.00407	CcSEcCtD
Ketoprofen—Salsalate—PTGS1—esophageal cancer	0.000257	0.0437	CrCbGaD
Ketoprofen—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000257	0.00398	CcSEcCtD
Ketoprofen—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000255	0.00396	CcSEcCtD
Ketoprofen—Ill-defined disorder—Cisplatin—esophageal cancer	0.000255	0.00395	CcSEcCtD
Ketoprofen—Renal failure—Capecitabine—esophageal cancer	0.000255	0.00395	CcSEcCtD
Ketoprofen—Myocardial infarction—Capecitabine—esophageal cancer	0.000254	0.00394	CcSEcCtD
Ketoprofen—Anaemia—Cisplatin—esophageal cancer	0.000254	0.00393	CcSEcCtD
Ketoprofen—Jaundice—Capecitabine—esophageal cancer	0.000252	0.00391	CcSEcCtD
Ketoprofen—Stomatitis—Capecitabine—esophageal cancer	0.000252	0.00391	CcSEcCtD
Ketoprofen—Conjunctivitis—Capecitabine—esophageal cancer	0.000252	0.0039	CcSEcCtD
Ketoprofen—Malaise—Cisplatin—esophageal cancer	0.000248	0.00384	CcSEcCtD
Ketoprofen—Haematuria—Capecitabine—esophageal cancer	0.000247	0.00383	CcSEcCtD
Ketoprofen—Suprofen—PTGS1—esophageal cancer	0.000247	0.0419	CrCbGaD
Ketoprofen—Epistaxis—Capecitabine—esophageal cancer	0.000244	0.00379	CcSEcCtD
Ketoprofen—Agranulocytosis—Capecitabine—esophageal cancer	0.000242	0.00375	CcSEcCtD
Ketoprofen—Convulsion—Cisplatin—esophageal cancer	0.000238	0.00369	CcSEcCtD
Ketoprofen—Myalgia—Cisplatin—esophageal cancer	0.000234	0.00362	CcSEcCtD
Ketoprofen—Rhinitis—Capecitabine—esophageal cancer	0.000233	0.00361	CcSEcCtD
Ketoprofen—Anxiety—Cisplatin—esophageal cancer	0.000233	0.00361	CcSEcCtD
Ketoprofen—Hepatitis—Capecitabine—esophageal cancer	0.000232	0.0036	CcSEcCtD
Ketoprofen—PTGS1—lung—esophageal cancer	0.000231	0.0131	CbGeAlD
Ketoprofen—Discomfort—Cisplatin—esophageal cancer	0.000231	0.00358	CcSEcCtD
Ketoprofen—Pharyngitis—Capecitabine—esophageal cancer	0.000231	0.00358	CcSEcCtD
Ketoprofen—Ketorolac—PTGS2—esophageal cancer	0.000228	0.0387	CrCbGaD
Ketoprofen—Carprofen—PTGS2—esophageal cancer	0.000228	0.0387	CrCbGaD
Ketoprofen—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000225	0.00349	CcSEcCtD
Ketoprofen—Oedema—Cisplatin—esophageal cancer	0.000224	0.00347	CcSEcCtD
Ketoprofen—Anaphylactic shock—Cisplatin—esophageal cancer	0.000224	0.00347	CcSEcCtD
Ketoprofen—Visual impairment—Capecitabine—esophageal cancer	0.000224	0.00347	CcSEcCtD
Ketoprofen—Infection—Cisplatin—esophageal cancer	0.000223	0.00345	CcSEcCtD
Ketoprofen—PTGS2—lung—esophageal cancer	0.000221	0.0126	CbGeAlD
Ketoprofen—Erythema multiforme—Capecitabine—esophageal cancer	0.00022	0.00341	CcSEcCtD
Ketoprofen—Thrombocytopenia—Cisplatin—esophageal cancer	0.000219	0.0034	CcSEcCtD
Ketoprofen—Bromfenac—PTGS2—esophageal cancer	0.000219	0.0371	CrCbGaD
Ketoprofen—Tachycardia—Cisplatin—esophageal cancer	0.000219	0.00339	CcSEcCtD
Ketoprofen—Tinnitus—Capecitabine—esophageal cancer	0.000217	0.00336	CcSEcCtD
Ketoprofen—Hyperhidrosis—Cisplatin—esophageal cancer	0.000217	0.00336	CcSEcCtD
Ketoprofen—Asthma—Methotrexate—esophageal cancer	0.000216	0.00335	CcSEcCtD
Ketoprofen—Flushing—Capecitabine—esophageal cancer	0.000216	0.00335	CcSEcCtD
Ketoprofen—Anorexia—Cisplatin—esophageal cancer	0.000214	0.00331	CcSEcCtD
Ketoprofen—Fenoprofen—PTGS1—esophageal cancer	0.000212	0.0361	CrCbGaD
Ketoprofen—Pancreatitis—Methotrexate—esophageal cancer	0.000212	0.00329	CcSEcCtD
Ketoprofen—Chills—Capecitabine—esophageal cancer	0.000209	0.00323	CcSEcCtD
Ketoprofen—Arrhythmia—Capecitabine—esophageal cancer	0.000208	0.00322	CcSEcCtD
Ketoprofen—Alopecia—Capecitabine—esophageal cancer	0.000205	0.00318	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000204	0.00316	CcSEcCtD
Ketoprofen—Erythema—Capecitabine—esophageal cancer	0.000202	0.00314	CcSEcCtD
Ketoprofen—Paraesthesia—Cisplatin—esophageal cancer	0.000201	0.00312	CcSEcCtD
Ketoprofen—Dyspnoea—Cisplatin—esophageal cancer	0.0002	0.0031	CcSEcCtD
Ketoprofen—Flatulence—Capecitabine—esophageal cancer	0.000199	0.00309	CcSEcCtD
Ketoprofen—Erectile dysfunction—Methotrexate—esophageal cancer	0.000199	0.00309	CcSEcCtD
Ketoprofen—Dysgeusia—Capecitabine—esophageal cancer	0.000198	0.00307	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000197	0.00306	CcSEcCtD
Ketoprofen—Mefenamic acid—PTGS1—esophageal cancer	0.000197	0.0335	CrCbGaD
Ketoprofen—Decreased appetite—Cisplatin—esophageal cancer	0.000195	0.00302	CcSEcCtD
Ketoprofen—Naproxen—PTGS1—esophageal cancer	0.000193	0.0328	CrCbGaD
Ketoprofen—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000193	0.003	CcSEcCtD
Ketoprofen—Drowsiness—Methotrexate—esophageal cancer	0.000193	0.00299	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000191	0.00296	CcSEcCtD
Ketoprofen—Renal failure—Methotrexate—esophageal cancer	0.00019	0.00294	CcSEcCtD
Ketoprofen—Stomatitis—Methotrexate—esophageal cancer	0.000188	0.00291	CcSEcCtD
Ketoprofen—Ill-defined disorder—Capecitabine—esophageal cancer	0.000188	0.00291	CcSEcCtD
Ketoprofen—Conjunctivitis—Methotrexate—esophageal cancer	0.000187	0.00291	CcSEcCtD
Ketoprofen—Anaemia—Capecitabine—esophageal cancer	0.000187	0.0029	CcSEcCtD
Ketoprofen—Tiaprofenic acid—PTGS2—esophageal cancer	0.000186	0.0316	CrCbGaD
Ketoprofen—Sweating—Methotrexate—esophageal cancer	0.000185	0.00287	CcSEcCtD
Ketoprofen—Feeling abnormal—Cisplatin—esophageal cancer	0.000185	0.00286	CcSEcCtD
Ketoprofen—Haematuria—Methotrexate—esophageal cancer	0.000184	0.00285	CcSEcCtD
Ketoprofen—Malaise—Capecitabine—esophageal cancer	0.000183	0.00283	CcSEcCtD
Ketoprofen—Epistaxis—Methotrexate—esophageal cancer	0.000182	0.00282	CcSEcCtD
Ketoprofen—Vertigo—Capecitabine—esophageal cancer	0.000182	0.00282	CcSEcCtD
Ketoprofen—Agranulocytosis—Methotrexate—esophageal cancer	0.00018	0.00279	CcSEcCtD
Ketoprofen—Palpitations—Capecitabine—esophageal cancer	0.000179	0.00277	CcSEcCtD
Ketoprofen—Nepafenac—PTGS2—esophageal cancer	0.000177	0.03	CrCbGaD
Ketoprofen—Hypertension—Capecitabine—esophageal cancer	0.000175	0.00271	CcSEcCtD
Ketoprofen—Hepatitis—Methotrexate—esophageal cancer	0.000173	0.00268	CcSEcCtD
Ketoprofen—Magnesium salicylate—PTGS2—esophageal cancer	0.000173	0.0294	CrCbGaD
Ketoprofen—Myalgia—Capecitabine—esophageal cancer	0.000172	0.00267	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—esophageal cancer	0.000172	0.00266	CcSEcCtD
Ketoprofen—Anxiety—Capecitabine—esophageal cancer	0.000172	0.00266	CcSEcCtD
Ketoprofen—Discomfort—Capecitabine—esophageal cancer	0.00017	0.00264	CcSEcCtD
Ketoprofen—Fenbufen—PTGS2—esophageal cancer	0.000169	0.0287	CrCbGaD
Ketoprofen—Dry mouth—Capecitabine—esophageal cancer	0.000169	0.00261	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—esophageal cancer	0.000167	0.00259	CcSEcCtD
Ketoprofen—Confusional state—Capecitabine—esophageal cancer	0.000167	0.00258	CcSEcCtD
Ketoprofen—Oedema—Capecitabine—esophageal cancer	0.000165	0.00256	CcSEcCtD
Ketoprofen—Hypersensitivity—Cisplatin—esophageal cancer	0.000165	0.00256	CcSEcCtD
Ketoprofen—Infection—Capecitabine—esophageal cancer	0.000164	0.00254	CcSEcCtD
Ketoprofen—Erythema multiforme—Methotrexate—esophageal cancer	0.000164	0.00254	CcSEcCtD
Ketoprofen—Shock—Capecitabine—esophageal cancer	0.000163	0.00252	CcSEcCtD
Ketoprofen—Thrombocytopenia—Capecitabine—esophageal cancer	0.000162	0.00251	CcSEcCtD
Ketoprofen—Tinnitus—Methotrexate—esophageal cancer	0.000161	0.0025	CcSEcCtD
Ketoprofen—Tachycardia—Capecitabine—esophageal cancer	0.000161	0.0025	CcSEcCtD
Ketoprofen—Asthenia—Cisplatin—esophageal cancer	0.000161	0.00249	CcSEcCtD
Ketoprofen—Hyperhidrosis—Capecitabine—esophageal cancer	0.00016	0.00248	CcSEcCtD
Ketoprofen—PTGS1—lymph node—esophageal cancer	0.000158	0.00898	CbGeAlD
Ketoprofen—Anorexia—Capecitabine—esophageal cancer	0.000157	0.00244	CcSEcCtD
Ketoprofen—Chills—Methotrexate—esophageal cancer	0.000155	0.00241	CcSEcCtD
Ketoprofen—Diarrhoea—Cisplatin—esophageal cancer	0.000153	0.00238	CcSEcCtD
Ketoprofen—Alopecia—Methotrexate—esophageal cancer	0.000153	0.00237	CcSEcCtD
Ketoprofen—PTGS2—lymph node—esophageal cancer	0.000151	0.00859	CbGeAlD
Ketoprofen—Erythema—Methotrexate—esophageal cancer	0.000151	0.00234	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00015	0.00233	CcSEcCtD
Ketoprofen—Insomnia—Capecitabine—esophageal cancer	0.000149	0.00232	CcSEcCtD
Ketoprofen—Paraesthesia—Capecitabine—esophageal cancer	0.000148	0.0023	CcSEcCtD
Ketoprofen—Dysgeusia—Methotrexate—esophageal cancer	0.000148	0.00229	CcSEcCtD
Ketoprofen—Dyspnoea—Capecitabine—esophageal cancer	0.000147	0.00228	CcSEcCtD
Ketoprofen—Salsalate—PTGS2—esophageal cancer	0.000147	0.025	CrCbGaD
Ketoprofen—Dyspepsia—Capecitabine—esophageal cancer	0.000145	0.00225	CcSEcCtD
Ketoprofen—Decreased appetite—Capecitabine—esophageal cancer	0.000144	0.00223	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000143	0.00221	CcSEcCtD
Ketoprofen—Vomiting—Cisplatin—esophageal cancer	0.000142	0.00221	CcSEcCtD
Ketoprofen—Fatigue—Capecitabine—esophageal cancer	0.000142	0.00221	CcSEcCtD
Ketoprofen—Rash—Cisplatin—esophageal cancer	0.000141	0.00219	CcSEcCtD
Ketoprofen—Constipation—Capecitabine—esophageal cancer	0.000141	0.00219	CcSEcCtD
Ketoprofen—Dermatitis—Cisplatin—esophageal cancer	0.000141	0.00219	CcSEcCtD
Ketoprofen—Mebendazole—ABCB1—esophageal cancer	0.000141	0.0239	CrCbGaD
Ketoprofen—Suprofen—PTGS2—esophageal cancer	0.000141	0.0239	CrCbGaD
Ketoprofen—Ill-defined disorder—Methotrexate—esophageal cancer	0.00014	0.00217	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—esophageal cancer	0.000139	0.00216	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS1—esophageal cancer	0.000139	0.0235	CrCbGaD
Ketoprofen—Feeling abnormal—Capecitabine—esophageal cancer	0.000136	0.00211	CcSEcCtD
Ketoprofen—Malaise—Methotrexate—esophageal cancer	0.000136	0.00211	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—esophageal cancer	0.000135	0.0021	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000135	0.00209	CcSEcCtD
Ketoprofen—Nausea—Cisplatin—esophageal cancer	0.000133	0.00206	CcSEcCtD
Ketoprofen—Urticaria—Capecitabine—esophageal cancer	0.000131	0.00203	CcSEcCtD
Ketoprofen—Abdominal pain—Capecitabine—esophageal cancer	0.000131	0.00202	CcSEcCtD
Ketoprofen—Convulsion—Methotrexate—esophageal cancer	0.000131	0.00202	CcSEcCtD
Ketoprofen—Myalgia—Methotrexate—esophageal cancer	0.000128	0.00199	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—esophageal cancer	0.000127	0.00196	CcSEcCtD
Ketoprofen—Confusional state—Methotrexate—esophageal cancer	0.000124	0.00192	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methotrexate—esophageal cancer	0.000123	0.00191	CcSEcCtD
Ketoprofen—Infection—Methotrexate—esophageal cancer	0.000122	0.00189	CcSEcCtD
Ketoprofen—Hypersensitivity—Capecitabine—esophageal cancer	0.000122	0.00189	CcSEcCtD
Ketoprofen—Fenoprofen—PTGS2—esophageal cancer	0.000121	0.0206	CrCbGaD
Ketoprofen—Thrombocytopenia—Methotrexate—esophageal cancer	0.00012	0.00187	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methotrexate—esophageal cancer	0.000119	0.00184	CcSEcCtD
Ketoprofen—Asthenia—Capecitabine—esophageal cancer	0.000119	0.00184	CcSEcCtD
Ketoprofen—Anorexia—Methotrexate—esophageal cancer	0.000117	0.00182	CcSEcCtD
Ketoprofen—Pruritus—Capecitabine—esophageal cancer	0.000117	0.00181	CcSEcCtD
Ketoprofen—Diarrhoea—Capecitabine—esophageal cancer	0.000113	0.00175	CcSEcCtD
Ketoprofen—Mefenamic acid—PTGS2—esophageal cancer	0.000113	0.0191	CrCbGaD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000112	0.00174	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—esophageal cancer	0.000111	0.00172	CcSEcCtD
Ketoprofen—Naproxen—PTGS2—esophageal cancer	0.000111	0.0188	CrCbGaD
Ketoprofen—Paraesthesia—Methotrexate—esophageal cancer	0.00011	0.00171	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—esophageal cancer	0.00011	0.0017	CcSEcCtD
Ketoprofen—Somnolence—Methotrexate—esophageal cancer	0.000109	0.00169	CcSEcCtD
Ketoprofen—Dizziness—Capecitabine—esophageal cancer	0.000109	0.00169	CcSEcCtD
Ketoprofen—Dyspepsia—Methotrexate—esophageal cancer	0.000108	0.00168	CcSEcCtD
Ketoprofen—Decreased appetite—Methotrexate—esophageal cancer	0.000107	0.00166	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000106	0.00165	CcSEcCtD
Ketoprofen—Fatigue—Methotrexate—esophageal cancer	0.000106	0.00164	CcSEcCtD
Ketoprofen—Vomiting—Capecitabine—esophageal cancer	0.000105	0.00163	CcSEcCtD
Ketoprofen—Rash—Capecitabine—esophageal cancer	0.000104	0.00161	CcSEcCtD
Ketoprofen—Dermatitis—Capecitabine—esophageal cancer	0.000104	0.00161	CcSEcCtD
Ketoprofen—Headache—Capecitabine—esophageal cancer	0.000103	0.0016	CcSEcCtD
Ketoprofen—Feeling abnormal—Methotrexate—esophageal cancer	0.000101	0.00157	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000101	0.00156	CcSEcCtD
Ketoprofen—Nausea—Capecitabine—esophageal cancer	9.81e-05	0.00152	CcSEcCtD
Ketoprofen—Urticaria—Methotrexate—esophageal cancer	9.77e-05	0.00151	CcSEcCtD
Ketoprofen—Abdominal pain—Methotrexate—esophageal cancer	9.72e-05	0.00151	CcSEcCtD
Ketoprofen—Hypersensitivity—Methotrexate—esophageal cancer	9.06e-05	0.0014	CcSEcCtD
Ketoprofen—Asthenia—Methotrexate—esophageal cancer	8.82e-05	0.00137	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—esophageal cancer	8.7e-05	0.00135	CcSEcCtD
Ketoprofen—Diarrhoea—Methotrexate—esophageal cancer	8.41e-05	0.0013	CcSEcCtD
Ketoprofen—Dizziness—Methotrexate—esophageal cancer	8.13e-05	0.00126	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS2—esophageal cancer	7.93e-05	0.0135	CrCbGaD
Ketoprofen—Vomiting—Methotrexate—esophageal cancer	7.82e-05	0.00121	CcSEcCtD
Ketoprofen—Rash—Methotrexate—esophageal cancer	7.75e-05	0.0012	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—esophageal cancer	7.75e-05	0.0012	CcSEcCtD
Ketoprofen—Headache—Methotrexate—esophageal cancer	7.7e-05	0.00119	CcSEcCtD
Ketoprofen—Nausea—Methotrexate—esophageal cancer	7.3e-05	0.00113	CcSEcCtD
Ketoprofen—PTGS2—Disease—ELMO1—esophageal cancer	1.91e-05	0.000183	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—BLVRB—esophageal cancer	1.89e-05	0.000182	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC52A3—esophageal cancer	1.89e-05	0.000182	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ALDOB—esophageal cancer	1.89e-05	0.000181	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ERBB2—esophageal cancer	1.89e-05	0.000181	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ENO1—esophageal cancer	1.89e-05	0.000181	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS1—esophageal cancer	1.89e-05	0.000181	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.88e-05	0.000181	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TPI1—esophageal cancer	1.87e-05	0.000179	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—GSTO1—esophageal cancer	1.87e-05	0.000179	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PSME1—esophageal cancer	1.86e-05	0.000178	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PSME2—esophageal cancer	1.86e-05	0.000178	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GAPDH—esophageal cancer	1.82e-05	0.000175	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ADH1B—esophageal cancer	1.81e-05	0.000174	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOTCH2—esophageal cancer	1.81e-05	0.000174	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CA2—esophageal cancer	1.81e-05	0.000173	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CRABP1—esophageal cancer	1.81e-05	0.000173	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CA2—esophageal cancer	1.8e-05	0.000172	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ALDOB—esophageal cancer	1.79e-05	0.000172	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.77e-05	0.00017	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.77e-05	0.00017	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.76e-05	0.000169	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TYMP—esophageal cancer	1.73e-05	0.000166	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HIST1H2BM—esophageal cancer	1.73e-05	0.000165	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—GAPDH—esophageal cancer	1.73e-05	0.000165	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNG7—esophageal cancer	1.72e-05	0.000165	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.7e-05	0.000163	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.69e-05	0.000162	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP26A1—esophageal cancer	1.69e-05	0.000162	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PLCE1—esophageal cancer	1.68e-05	0.000161	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ADH7—esophageal cancer	1.68e-05	0.000161	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PLCE1—esophageal cancer	1.67e-05	0.00016	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ADH7—esophageal cancer	1.67e-05	0.00016	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCND1—esophageal cancer	1.67e-05	0.00016	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.66e-05	0.000159	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.66e-05	0.000159	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.65e-05	0.000158	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ALOX15—esophageal cancer	1.64e-05	0.000157	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—ABL1—esophageal cancer	1.64e-05	0.000157	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.62e-05	0.000155	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CDKN1A—esophageal cancer	1.61e-05	0.000155	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CA1—esophageal cancer	1.61e-05	0.000154	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.61e-05	0.000154	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ALDH2—esophageal cancer	1.61e-05	0.000154	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFBR2—esophageal cancer	1.61e-05	0.000154	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	1.6e-05	0.000154	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—EP300—esophageal cancer	1.6e-05	0.000153	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTO1—esophageal cancer	1.57e-05	0.00015	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TPI1—esophageal cancer	1.57e-05	0.00015	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EP300—esophageal cancer	1.54e-05	0.000147	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTT1—esophageal cancer	1.53e-05	0.000147	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—XIAP—esophageal cancer	1.53e-05	0.000146	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SMAD4—esophageal cancer	1.52e-05	0.000146	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP2A6—esophageal cancer	1.51e-05	0.000145	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	1.51e-05	0.000144	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.51e-05	0.000144	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ALDOB—esophageal cancer	1.5e-05	0.000144	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.48e-05	0.000141	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CA2—esophageal cancer	1.47e-05	0.000141	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ADH1B—esophageal cancer	1.47e-05	0.000141	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GAPDH—esophageal cancer	1.45e-05	0.000139	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.44e-05	0.000138	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.44e-05	0.000138	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.44e-05	0.000138	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ENO1—esophageal cancer	1.43e-05	0.000137	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CRABP1—esophageal cancer	1.43e-05	0.000137	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—B2M—esophageal cancer	1.42e-05	0.000136	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PSME2—esophageal cancer	1.41e-05	0.000135	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PSME1—esophageal cancer	1.41e-05	0.000135	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TYMP—esophageal cancer	1.41e-05	0.000135	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TYMP—esophageal cancer	1.4e-05	0.000134	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.4e-05	0.000134	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.38e-05	0.000132	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—HMOX1—esophageal cancer	1.38e-05	0.000132	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.37e-05	0.000131	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.37e-05	0.000131	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ADH7—esophageal cancer	1.37e-05	0.000131	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP26A1—esophageal cancer	1.36e-05	0.000131	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNG7—esophageal cancer	1.36e-05	0.000131	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ENO1—esophageal cancer	1.36e-05	0.00013	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.35e-05	0.00013	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.35e-05	0.000129	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PSME1—esophageal cancer	1.34e-05	0.000128	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PSME2—esophageal cancer	1.34e-05	0.000128	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—esophageal cancer	1.34e-05	0.000128	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.34e-05	0.000128	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ALOX15—esophageal cancer	1.33e-05	0.000127	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ABCB1—esophageal cancer	1.32e-05	0.000127	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EGFR—esophageal cancer	1.31e-05	0.000125	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CALR—esophageal cancer	1.29e-05	0.000123	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ALDH2—esophageal cancer	1.28e-05	0.000122	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.28e-05	0.000122	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TPI1—esophageal cancer	1.28e-05	0.000122	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTO1—esophageal cancer	1.27e-05	0.000121	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TPI1—esophageal cancer	1.27e-05	0.000121	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HIF1A—esophageal cancer	1.25e-05	0.000119	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FBXW7—esophageal cancer	1.24e-05	0.000119	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.23e-05	0.000118	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.22e-05	0.000117	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP1B1—esophageal cancer	1.22e-05	0.000117	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ALDOB—esophageal cancer	1.22e-05	0.000116	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTT1—esophageal cancer	1.22e-05	0.000116	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP2A6—esophageal cancer	1.2e-05	0.000115	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.2e-05	0.000115	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.2e-05	0.000115	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KDR—esophageal cancer	1.19e-05	0.000114	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS2—esophageal cancer	1.18e-05	0.000113	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PIK3CA—esophageal cancer	1.18e-05	0.000113	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.18e-05	0.000113	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GAPDH—esophageal cancer	1.17e-05	0.000112	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.17e-05	0.000112	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CRABP1—esophageal cancer	1.16e-05	0.000111	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TYMP—esophageal cancer	1.15e-05	0.00011	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.15e-05	0.00011	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—esophageal cancer	1.15e-05	0.00011	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTGS1—esophageal cancer	1.14e-05	0.000109	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ENO1—esophageal cancer	1.14e-05	0.000109	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PIK3CA—esophageal cancer	1.14e-05	0.000109	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PSME1—esophageal cancer	1.12e-05	0.000108	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PSME2—esophageal cancer	1.12e-05	0.000108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOTCH1—esophageal cancer	1.12e-05	0.000108	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.12e-05	0.000107	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNG7—esophageal cancer	1.11e-05	0.000106	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNG7—esophageal cancer	1.1e-05	0.000106	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—esophageal cancer	1.1e-05	0.000105	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.09e-05	0.000104	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—CREBBP—esophageal cancer	1.06e-05	0.000102	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HMOX1—esophageal cancer	1.05e-05	0.0001	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.04e-05	9.96e-05	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	1.04e-05	9.96e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TPI1—esophageal cancer	1.04e-05	9.95e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.04e-05	9.95e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ALDH2—esophageal cancer	1.03e-05	9.9e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.03e-05	9.84e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CREBBP—esophageal cancer	1.02e-05	9.75e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFBR2—esophageal cancer	1.01e-05	9.64e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ABCB1—esophageal cancer	1e-05	9.62e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—esophageal cancer	1e-05	9.58e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.98e-06	9.57e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.95e-06	9.53e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTT1—esophageal cancer	9.89e-06	9.47e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTT1—esophageal cancer	9.83e-06	9.42e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP2A6—esophageal cancer	9.77e-06	9.37e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.74e-06	9.33e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP2A6—esophageal cancer	9.72e-06	9.31e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP1B1—esophageal cancer	9.68e-06	9.28e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.68e-06	9.28e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.58e-06	9.18e-05	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CA—esophageal cancer	9.55e-06	9.15e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SMAD4—esophageal cancer	9.52e-06	9.12e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS3—esophageal cancer	9.52e-06	9.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.49e-06	9.1e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS1—esophageal cancer	9.27e-06	8.88e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ENO1—esophageal cancer	9.27e-06	8.88e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS1—esophageal cancer	9.21e-06	8.83e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ENO1—esophageal cancer	9.21e-06	8.83e-05	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.21e-06	8.82e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PSME1—esophageal cancer	9.13e-06	8.75e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PSME2—esophageal cancer	9.13e-06	8.75e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOS3—esophageal cancer	9.11e-06	8.73e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP19A1—esophageal cancer	9.1e-06	8.72e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PSME2—esophageal cancer	9.08e-06	8.7e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PSME1—esophageal cancer	9.08e-06	8.7e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNG7—esophageal cancer	9.03e-06	8.65e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CREBBP—esophageal cancer	8.82e-06	8.46e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CA—esophageal cancer	8.68e-06	8.31e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—esophageal cancer	8.52e-06	8.16e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.46e-06	8.11e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HMOX1—esophageal cancer	8.31e-06	7.96e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.15e-06	7.81e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTT1—esophageal cancer	8.05e-06	7.71e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ABCB1—esophageal cancer	7.97e-06	7.64e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.97e-06	7.64e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.96e-06	7.62e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.93e-06	7.6e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.92e-06	7.59e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NOS3—esophageal cancer	7.9e-06	7.57e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP1B1—esophageal cancer	7.88e-06	7.55e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP1B1—esophageal cancer	7.83e-06	7.51e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HIF1A—esophageal cancer	7.79e-06	7.46e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.59e-06	7.28e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.54e-06	7.23e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ENO1—esophageal cancer	7.54e-06	7.23e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—esophageal cancer	7.53e-06	7.21e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PSME2—esophageal cancer	7.43e-06	7.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PSME1—esophageal cancer	7.43e-06	7.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP19A1—esophageal cancer	7.41e-06	7.1e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP19A1—esophageal cancer	7.37e-06	7.06e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1A—esophageal cancer	7.28e-06	6.98e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EP300—esophageal cancer	7.24e-06	6.94e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—esophageal cancer	7.23e-06	6.92e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS2—esophageal cancer	7.09e-06	6.79e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOTCH1—esophageal cancer	7.02e-06	6.72e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EP300—esophageal cancer	6.93e-06	6.64e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HMOX1—esophageal cancer	6.76e-06	6.48e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HMOX1—esophageal cancer	6.72e-06	6.44e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CREBBP—esophageal cancer	6.71e-06	6.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.63e-06	6.35e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.59e-06	6.32e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.49e-06	6.22e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ABCB1—esophageal cancer	6.49e-06	6.22e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ABCB1—esophageal cancer	6.45e-06	6.18e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.41e-06	6.14e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CREBBP—esophageal cancer	6.36e-06	6.1e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—esophageal cancer	6.04e-06	5.78e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.03e-06	5.78e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.03e-06	5.78e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NOS3—esophageal cancer	6.01e-06	5.76e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—EP300—esophageal cancer	6.01e-06	5.76e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—esophageal cancer	5.91e-06	5.66e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS3—esophageal cancer	5.7e-06	5.46e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.5e-06	5.27e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—esophageal cancer	5.5e-06	5.27e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.4e-06	5.17e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CA—esophageal cancer	5.36e-06	5.13e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CREBBP—esophageal cancer	5.33e-06	5.11e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—esophageal cancer	5.33e-06	5.11e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.28e-06	5.06e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—esophageal cancer	5.18e-06	4.97e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CA—esophageal cancer	5.13e-06	4.91e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—esophageal cancer	4.96e-06	4.75e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.91e-06	4.7e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.88e-06	4.67e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NOS3—esophageal cancer	4.77e-06	4.57e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—EP300—esophageal cancer	4.57e-06	4.38e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1A—esophageal cancer	4.55e-06	4.36e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	4.45e-06	4.26e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CREBBP—esophageal cancer	4.34e-06	4.15e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EP300—esophageal cancer	4.33e-06	4.15e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CREBBP—esophageal cancer	4.31e-06	4.13e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.99e-06	3.83e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NOS3—esophageal cancer	3.88e-06	3.72e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NOS3—esophageal cancer	3.86e-06	3.7e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—esophageal cancer	3.78e-06	3.62e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—esophageal cancer	3.69e-06	3.54e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—EP300—esophageal cancer	3.63e-06	3.48e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.55e-06	3.4e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—esophageal cancer	3.53e-06	3.38e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.53e-06	3.38e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CA—esophageal cancer	3.38e-06	3.24e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CA—esophageal cancer	3.21e-06	3.07e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NOS3—esophageal cancer	3.16e-06	3.03e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—EP300—esophageal cancer	2.95e-06	2.83e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—EP300—esophageal cancer	2.94e-06	2.81e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.89e-06	2.77e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CA—esophageal cancer	2.69e-06	2.57e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—EP300—esophageal cancer	2.4e-06	2.3e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.18e-06	2.09e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CA—esophageal cancer	2.17e-06	2.08e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.78e-06	1.7e-05	CbGpPWpGaD
